Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Year: 2025
Type: article
Source: Blood Cancer Journal
Authors: Fieke W. Hoff, Ying Huang, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, William G. Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca L. Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K. Curran, Kristin L. Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, John C. Byrd, Yazan F. Madanat
Institutions: The University of Texas Southwestern Medical Center, The Ohio State University, Oregon Health & Science University, OHSU Knight Cancer Institute, Memorial Sloan Kettering Cancer Center, University of Kansas Medical Center, Boston Foundation, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Emory University, Winship Cancer Institute, University of Chicago, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of Utah, Medical College of Wisconsin, Versiti Blood Center of Wisconsin, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of California, San Francisco, Mayo Clinic, Mayo Clinic in Florida, University of California, Los Angeles, University of Cincinnati, Blood Cancer United
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,290
OpenAlex ID: W4409151653